| Trial ID: | L4384 |
| Source ID: | NCT05035849
|
| Associated Drug: |
Sitagliptin And Acarbose
|
| Title: |
Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: sitagliptin and acarbose
|
| Outcome Measures: |
Primary: Glycemic variations, CV, Endpoint at the third month | Secondary: Glycemic variations, TIR, Endpoint at the third month
|
| Sponsor/Collaborators: |
Sponsor: Nanjing First Hospital, Nanjing Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2020-01-30
|
| Completion Date: |
2021-05-05
|
| Results First Posted: |
|
| Last Update Posted: |
2021-09-05
|
| Locations: |
Gu Gao, Nanjing, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05035849
|
